| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PNAS..10913549Z |
| P356 | DOI | 10.1073/PNAS.1205707109 |
| P932 | PMC publication ID | 3427122 |
| P698 | PubMed publication ID | 22869745 |
| P5875 | ResearchGate publication ID | 235608258 |
| P50 | author | Neil Kelleher | Q6988803 |
| Paul M. Thomas | Q55396914 | ||
| Steve Sweet | Q57642423 | ||
| Yupeng Zheng | Q58327492 | ||
| Jeremiah D Tipton | Q114996787 | ||
| P2093 | author name string | Relja Popovic | |
| Jonathan D Licht | |||
| Eva Martinez-Garcia | |||
| P2860 | cites work | Proteome analysis using selective incorporation of isotopically labeled amino acids | Q58069252 |
| Pervasive combinatorial modification of histone H3 in human cells | Q80387197 | ||
| Analysis of dynamic changes in post-translational modifications of human histones during cell cycle by mass spectrometry | Q80651825 | ||
| Translating the Histone Code | Q22065840 | ||
| Combinatorial patterns of histone acetylations and methylations in the human genome | Q24647290 | ||
| Role of the polycomb protein EED in the propagation of repressive histone marks | Q27657483 | ||
| Histone methylation by PRC2 is inhibited by active chromatin marks | Q27667743 | ||
| Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin | Q27851546 | ||
| High-resolution profiling of histone methylations in the human genome | Q27860906 | ||
| The language of covalent histone modifications | Q27860931 | ||
| Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases | Q28278969 | ||
| Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27) | Q29147438 | ||
| Mapping and analysis of chromatin state dynamics in nine human cell types | Q29547552 | ||
| MLL translocations, histone modifications and leukaemia stem-cell development | Q29615368 | ||
| Skyline: an open source document editor for creating and analyzing targeted proteomics experiments | Q30080030 | ||
| Chemical derivatization of histones for facilitated analysis by mass spectrometry. | Q30370270 | ||
| Regulation of the DNA damage response and gene expression by the Dot1L histone methyltransferase and the 53Bp1 tumour suppressor | Q31001642 | ||
| The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate | Q33553524 | ||
| In vivo residue-specific histone methylation dynamics | Q33661504 | ||
| Kinetics of re-establishing H3K79 methylation marks in global human chromatin. | Q34236695 | ||
| Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas | Q34397318 | ||
| Global turnover of histone post-translational modifications and variants in human cells | Q34419379 | ||
| The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. | Q34568855 | ||
| H3K36 methylation antagonizes PRC2-mediated H3K27 methylation | Q34624209 | ||
| NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming | Q35569571 | ||
| Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks | Q35749545 | ||
| The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. | Q36384699 | ||
| Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells | Q36670103 | ||
| Mechanisms of epigenetic inheritance | Q36805020 | ||
| Understanding the language of Lys36 methylation at histone H3. | Q37672319 | ||
| Epigenetic inheritance: uncontested? | Q37842140 | ||
| A modified "cross-talk" between histone H2B Lys-120 ubiquitination and H3 Lys-79 methylation. | Q39707641 | ||
| The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor | Q40031496 | ||
| Establishment of histone modifications after chromatin assembly | Q43064142 | ||
| Enhanced protein detection using a trapping mode on a hybrid quadrupole linear ion trap (Q-Trap). | Q43119051 | ||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13549-13554 | |
| P577 | publication date | 2012-08-06 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Total kinetic analysis reveals how combinatorial methylation patterns are established on lysines 27 and 36 of histone H3 | |
| P478 | volume | 109 |
| Q92853069 | A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant |
| Q37008808 | A quantitative atlas of histone modification signatures from human cancer cells |
| Q42688880 | A scalable moment-closure approximation for large-scale biochemical reaction networks |
| Q41553016 | Acetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets |
| Q64937209 | An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia. |
| Q64118756 | Benchmark Problems for Dynamic Modeling of Intracellular Processes |
| Q61031838 | Capturing the Onset of PRC2-Mediated Repressive Domain Formation |
| Q35945350 | Cis-existence of H3K27me3 and H3K36me2 in mouse embryonic stem cells revealed by specific ions of isobaric modification chromatogram |
| Q35638823 | Drawbacks in the use of unconventional hydrophobic anhydrides for histone derivatization in bottom-up proteomics PTM analysis |
| Q38884048 | Epiproteomics: quantitative analysis of histone marks and codes by mass spectrometry |
| Q52332024 | Extensive and systematic rewiring of histone post-translational modifications in cancer model systems. |
| Q38906678 | H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer |
| Q58977715 | High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2 |
| Q92986387 | Histone H3 tail binds a unique sensing pocket in EZH2 to activate the PRC2 methyltransferase |
| Q34133622 | Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation |
| Q61443681 | Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma |
| Q26775027 | Histone methyltransferases: novel targets for tumor and developmental defects |
| Q51358936 | MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents. |
| Q41966378 | Measurement of acetylation turnover at distinct lysines in human histones identifies long-lived acetylation sites. |
| Q38225521 | Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destination |
| Q58587915 | Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma |
| Q99418948 | NSD1-deposited H3K36me2 directs de novo methylation in the mouse male germline and counteracts Polycomb-associated silencing |
| Q37240015 | NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation. |
| Q37401600 | Oncogene-induced cellular senescence elicits an anti-Warburg effect |
| Q92429871 | PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation |
| Q90423710 | PRC2 functions in development and congenital disorders |
| Q92254249 | PRC2 is high maintenance |
| Q36335870 | Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma |
| Q37463690 | Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies |
| Q64882453 | Profiling of Epigenetic Features in Clinical Samples Reveals Novel Widespread Changes in Cancer. |
| Q27014943 | Proteomics in epigenetics: new perspectives for cancer research |
| Q91676965 | Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts |
| Q90110751 | PyBioNetFit and the Biological Property Specification Language |
| Q30375585 | Quantitative proteomic analysis of histone modifications |
| Q34954489 | Recombinant antibodies to histone post-translational modifications |
| Q34288082 | Site-specific human histone H3 methylation stability: fast K4me3 turnover |
| Q58760210 | Stability of histone post-translational modifications in samples derived from liver tissue and primary hepatic cells |
| Q34157702 | Stable-isotope-labeled histone peptide library for histone post-translational modification and variant quantification by mass spectrometry |
| Q36445523 | Targeting EZH2 and PRC2 dependence as novel anticancer therapy |
| Q39134084 | The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer |
| Q26782196 | The interplay of histone modifications - writers that read |
| Q36604417 | Top-down and Middle-down Protein Analysis Reveals that Intact and Clipped Human Histones Differ in Post-translational Modification Patterns |
| Q61816131 | USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia |
| Q36745131 | Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression |
| Q90591550 | Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer |
Search more.